Featured Articles in the Current Issue
A less invasive canaloplasty could be simpler and safer for patients.
Parsing the data can benefit patients.
Are we ignoring a crucial element of vision?
Entrants to the field change the treatment paradigm.
Examining risk in diagnosis and treatment.
Ensuring the best care for patients who travel often.
Departments and Columns
Glaucoma News Briefs
- UK Study: SLT Should Be First-Line Treatment
- FDA Approves Aerie’s Rocklatan IOP-Lowering Combination
- Two Types of Tonometer Vary in IOP Readings
- Hybrid MIGS Procedure Proves Effective
- Sight Sciences’ TRAB360 Effective in Single-Center Study
- iStent Trials Show Effectiveness at 5 Years
- Ivantis Reports 3-Year Data for Hydrus Microstent
- Bimatoprost SR Durability Excels in Early Trial
- Rhopressa Effective in “Real-World” Study
- Simplified Trabeculectomy Shows Fewer Complications
- Pivotal iStent Inject Data Led to Approval
- Virtual Reality May Help in Glaucoma Detection
- Glaukos to Distribute Santen Glaucoma Device
- Microdose Latanoprost Delivery Set for Broad Patient Base
- Ivantis Reports 2-Year Hydrus Trial Data
- Artificial Intelligence Holds Promise for Earlier Glaucoma Detection
- Statin Use May Reduce Glaucoma Risk
- Algorithm Captures Predictive Glaucoma Data
- AGS Innovator Award Given to Mary G. Lynch, MD
- Shaffer Prize for Innovative Glaucoma Research Awarded to Adriana Di Polo, PhD
- Telemedicine Screening Effort Deemed a Success
- Q BioMed Licenses Glaucoma Progression Biomarker
- Study: Repeat SLT proves effective for OAG
- Survey Identifies Resistance to First-Line SLT